Showing results (161-170 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|July 12, 2017
Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasisN D Loft, L Skov, L Iversen, et al.
The Pharmacogenomics Journal|January 13, 2010
A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitorC-M Chung, R-Y Wang, J-W Chen, et al.
The Pharmacogenomics Journal|February 4, 2010
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancerT F Hansen, K-L Garm Spindler, R F Andersen, et al.
The Pharmacogenomics Journal|June 2, 2018
Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestryMarguerite R Irvin, Colleen M Sitlani, Raymond Noordam, et al.
The Pharmacogenomics Journal|March 11, 2009
Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human liversRoza Ghotbi, Alvin Gomez, Lili Milani, et al.
The Pharmacogenomics Journal|May 13, 2009
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patientsD Caronia, A Patiño-García, R L Milne, et al.
The Pharmacogenomics Journal|February 25, 2009
Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathyTomomi Furihata, Naoki Satoh, Tomoharu Ohishi, et al.
The Pharmacogenomics Journal|April 22, 2009
A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patientsC Demacq, V B Vasconcellos, A M Marcaccini, et al.
The Pharmacogenomics Journal|August 4, 2004
Differential qualitative responses to rivastigmine in APOE epsilon 4 carriers and noncarriersM Farlow, R Lane, S Kudaravalli, et al.
The Pharmacogenomics Journal|August 4, 2004
Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neuronsH Kanai, A Sawa, R-W Chen, et al.
Pageof 135